EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Persistent Hyperglycaemia and Transient Dysglycaemia in Tuberculosis: Evaluating the Bidirectional Interaction With Type‐2 Diabetes Mellitus and Clinical Outcomes

Augustine Asare Boadu, Prince Asare, Michelle Yeboah-Manu, Stephen Osei-Wusu, Emelia Danso Konadu, Adwoa Asante-Poku iD, Yayra Klinogo, Abraham Adjei, Desmond Omane Acheampong, Jane S Afriyie-Mensah, Dorothy Yeboah-Manu, Yacoba Atiase

Tropical Medicine & International Health · 2026-04 · 31 (4) · 523-531

DOI: 10.1111/tmi.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tropical Medicine & International Health, online erschienen am 24.02.2026. Verfasst von Augustine Asare Boadu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hyperglycemia, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Poor glycaemic control, indicated by a haemoglobin A1c (HbA1c) level of 7% or higher, increases the risk of active tuberculosis (TB) in patients with diabetes, while active TB can worsen glucose tolerance and insulin resistance, contributing to type‐2 diabetes mellitus (DM) progression. The bidirectional relationship between TB and DM is well recognised, but the evolution of glycaemic status during TB treatment, particularly the distinction between transient and persistent dysglycaemia, is not well understood in high‐burden settings.

Methods

We conducted a prospective cohort study of 120 newly diagnosed pulmonary TB patients in Ghana, categorised as TB‐Only ( n = 66), TB with established DM on metformin (TB‐DM t , n = 39), and TB with dysglycaemia not requiring pharmacological therapy (TB‐DM nt , n = 15). HbA1c was measured at baseline, 3, 6 and 9 months.

Results

TB‐DM t patients were older, had higher BMI and persistently elevated HbA1c ( p < 0.001). In contrast, TB‐DM nt patients showed significant HbA1c decline during and after TB treatment, normalising by 6 months ( p < 0.016). Most TB‐Only patients maintained stable euglycaemia. Transient dysglycaemia resolved in TB‐DM nt , while persistent hyperglycaemia was confined to those with pre‐existing DM (TB‐DM t ).

Conclusion

Routine HbA1c monitoring during TB therapy can distinguish transient dysglycaemia from true diabetes, supporting more precise risk stratification and tailored management of TB patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HyperglycemiaTuberculosis, PulmonaryHumansGlycated HemoglobinFemaleMaleProspective StudiesMetforminMiddle AgedHypoglycemic AgentsAdultGhanaBlood GlucoseAntitubercular AgentsAged

Stichwörter der Autor:innen

TB‐diabetes comorbiditydiabetes mellitus (DM)dysglycaemiahaemoglobin A1c (HbA1c)tuberculosis (TB)

Substanzen

Glycated HemoglobinMetforminHypoglycemic AgentsBlood GlucoseAntitubercular Agentshemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
  • Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
  • University of Ghana Medical Center, University of Ghana, Legon, Ghana.
  • Department of Chest Diseases, Korle-Bu Teaching Hospital, Accra, Ghana.
  • University of Ghana Medical School, Accra, Ghana.
  • National Diabetes Management and Research Center, Korle-Bu Teaching Hospital, Accra, Ghana.

ORCID-Profile: Adwoa Asante-Poku

Förderung

  • European and Developing Countries Clinical Trials Partnership

Zitieren

APA

Boadu, A. A., Asare, P., Yeboah-Manu, M., Osei-Wusu, S., Konadu, E. D., Asante-Poku, A., Klinogo, Y., Adjei, A., Acheampong, D. O., Afriyie-Mensah, J. S., Yeboah-Manu, D., & Atiase, Y. (2026). Persistent Hyperglycaemia and Transient Dysglycaemia in Tuberculosis: Evaluating the Bidirectional Interaction With Type‐2 Diabetes Mellitus and Clinical Outcomes. Tropical Medicine & International Health, 31(4), 523-531. https://doi.org/10.1111/tmi.70102

Vancouver

Boadu AA, Asare P, Yeboah-Manu M, Osei-Wusu S, Konadu ED, Asante-Poku A, et al. Persistent Hyperglycaemia and Transient Dysglycaemia in Tuberculosis: Evaluating the Bidirectional Interaction With Type‐2 Diabetes Mellitus and Clinical Outcomes. Tropical Medicine & International Health. 2026;31(4):523-531. doi:10.1111/tmi.70102

BibTeX
@article{Boadu2026,
  author = {Boadu, Augustine Asare and Asare, Prince and Yeboah-Manu, Michelle and Osei-Wusu, Stephen and Konadu, Emelia Danso and Asante-Poku, Adwoa and Klinogo, Yayra and Adjei, Abraham and Acheampong, Desmond Omane and Afriyie-Mensah, Jane S and Yeboah-Manu, Dorothy and Atiase, Yacoba},
  title = {Persistent Hyperglycaemia and Transient Dysglycaemia in Tuberculosis: Evaluating the Bidirectional Interaction With Type‐2 Diabetes Mellitus and Clinical Outcomes},
  journal = {Tropical Medicine & International Health},
  year = {2026},
  volume = {31},
  number = {4},
  pages = {523--531},
  doi = {10.1111/tmi.70102}
}
Kostenlos starten →